Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Renal Cell Cancer”

713 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 713 results

Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Looking for participantsNCT04473781
What this trial is testing

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

Who this might be right for
Stage I Renal Cell CancerStage II Renal Cell Cancer
Jonsson Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT06401330
What this trial is testing

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Who this might be right for
Stage I Mixed Cell Type Kidney Wilms TumorStage II Mixed Cell Type Kidney Wilms TumorStage III Mixed Cell Type Kidney Wilms Tumor+1 more
Children's Oncology Group 1,656
Testing effectiveness (Phase 2)Ended earlyNCT00485563
What this trial is testing

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Endocyte 12
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00491075
What this trial is testing

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00444314
What this trial is testing

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
CASI Pharmaceuticals, Inc. 82
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing

SAbR For Oligo-Progressive Renal Cell Cancer.

Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT00422019
What this trial is testing

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 61
Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Testing effectiveness (Phase 2)Study completedNCT00101608
What this trial is testing

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Transitional Cell CarcinomaBladder NeoplasmsKidney Neoplasms+3 more
Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)Temporarily pausedNCT06059014
What this trial is testing

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients with Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 48
Testing effectiveness (Phase 2)Ended earlyNCT01482949
What this trial is testing

A Rollover Protocol for Subjects Previously Treated With AGS-003

Who this might be right for
Renal Cell Carcinoma
Argos Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT00066352
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT01835158
What this trial is testing

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 157
Testing effectiveness (Phase 2)Study completedNCT00625755
What this trial is testing

A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Beth Israel Deaconess Medical Center 40
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT01510119
What this trial is testing

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 40
Load More Results